We are live on ! Find out more

456 hedge funds and large institutions have $2.89B invested in Chemours in 2026 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 120 increasing their positions, 127 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

331% more call options, than puts

Call options by funds: $187M | Put options by funds: $43.3M

150% more funds holding in top 10

Funds holding in top 10: 4 → 10 (+6)

30% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 57

4% more funds holding

Funds holding: 438 → 456 (+18)

6% less repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 127

8% less capital inflows, than outflows

Capital inflows: $366M | Capital outflows: $398M

2.34% less ownership

Funds ownership: 89.95% → 87.61% (-2.3%)

Holders
456
Holders Change
+18
Holders Change %
+4.11%
% of All Funds
5.53%
Holding in Top 10
10
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+150%
% of All Funds
0.12%
New
74
Increased
120
Reduced
127
Closed
57
Calls
$187​M
Puts
$43.3​M
Net Calls
+$143​M
Net Calls Change
+$107​M

CC Hedge Fund Activity: Q1 2026 in Review

456 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2026, worth a combined $2.89B — up 82% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new CC positions and 57 closed out — a net gain of 17 holders — while 120 added to existing stakes and 127 trimmed.

The largest buyer was Wolf Hill Capital Management, opening a new position worth an estimated $64.2M. The largest seller was BlackRock, cutting an estimated $60.7M.

  • 456 institutional investors held Chemours (CC) as of Q1 2026, up from 438 in Q4 2025.
  • Funds reported $2.89B of Chemours stock for Q1 2026, up 82% quarter-over-quarter.
  • 74 funds opened new Chemours positions in Q1 2026 and 57 closed out, a net change of +17 holders.
  • The largest Chemours buyer in Q1 2026 was Wolf Hill Capital Management, an estimated $64.2M added.
  • The largest Chemours seller in Q1 2026 was BlackRock, an estimated $60.7M sold.

Based on aggregated 13F filings for Q1 2026.